Evidence mapPaperPMID 29296189Full record

ArticleOncotarget2017

Metformin affects thyroid function in male rats.

Xiaowen Hu, Yang Liu, Changmei Wang, Lulu Hou, Xiaoyan Zheng, Yeqiu Xu, Lin Ding, Shuguang Pang

Abstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. BothBiomolecules · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaowen HuDepartment of Infectious Diseases, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China.
Yang LiuSchool of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia Qld 4072, Australia.
Changmei WangDepartment of Endocrinology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China.
Lulu HouDepartment of Endocrinology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China.
Xiaoyan ZhengDepartment of Endocrinology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China.
Yeqiu XuDepartment of Endocrinology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China.
Lin DingDepartment of Endocrinology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China.
Shuguang PangDepartment of Endocrinology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An intriguing area of research in type 2 diabetes recently discovered association of metformin therapy with thyroid functional and morphological changes. We aimed to evaluate the external symptoms and biochemical indicators concerning thyroid function in rats treated with metformin. Male wistar rats were randomly divided into four groups: Group (D-/M-), Group (D-/M+), Group (D+/M-), and Group (D+/M+), according to whether they were induced to diabetic model or placed on metformin. Characteristics of food intake, body weight, and other external symptoms were recorded. Thyroid function, concluding serum thyrotropin (TSH), free triiodothyronine (FT3), free thyroxine (FT4), were measured. We found a significantly higher TSH and lower FT4 in rats in Group (D+/M-), compared with rats in Group (D-/M-), but no significant change in FT3 level. Rats on metformin treatment exhibited relatively lower body weight and symptoms like irritability and diarrhea, concomitant with marked increase in FT3 and FT4 , no matter if they were induced to diabetic model or not . A slight but significant reduction in TSH concentration was also observed in rats received metformin. These data reveal that metformin can modify thyroid function with corresponding clinical symptoms of hyperthyroidism in male rats. Metformin's contribution to suppress TSH and increase FT3, FT4 should arise our attention to its treatment interference in clinical practice.

Indexed as

free thyroxinefree triiodothyroninemetforminthyrotropintype 2 diabetes

Identifiers

PMID29296189
PMCPMC5746091

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.